{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:17:52Z","timestamp":1791317872696,"version":"4.3.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bpg.2010.07.008","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T17:40:39Z","timestamp":1298050839000},"page":"725-734","source":"Crossref","is-referenced-by-count":20,"title":["Inherited hepatocellular carcinoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Augusto","family":"Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pippa","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Hoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2010.07.008_bib1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.gastro.2003.12.049","article-title":"Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance","volume":"126","author":"Sangiovanni","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.008_bib2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","article-title":"Hepatocellular carcinoma: recent trends in the United States","volume":"127","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.008_bib3","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib5","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.008_bib6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1053\/jhep.2002.36939","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib7","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/350429a0","article-title":"Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa","volume":"350","author":"Bressac","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2010.07.008_bib9","first-page":"3","article-title":"A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People\u2019s Republic of China","volume":"3","author":"Qian","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpg.2010.07.008_bib10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2009.09.012","article-title":"Vinyl chloride and the liver","volume":"51","author":"Sherman","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/jhep.2001.22506","article-title":"Increased cancer risk in a cohort of 230 patients with hereditary haemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease","volume":"33","author":"Fracanzani","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib12","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis \u2013 a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib13","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.07.008_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-9966-29-18","article-title":"Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis","volume":"29","author":"Jin","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.008_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1097-0142(20000715)89:2<297::AID-CNCR14>3.0.CO;2-N","article-title":"Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients","volume":"89","author":"Pirisi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bpg.2010.07.008_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MOG.0b013e3282fcbc0f","article-title":"Inherited metabolic disease of the liver","volume":"24","author":"Taddei","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.008_bib17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2169\/internalmedicine.43.1042","article-title":"Hepatocellular carcinoma associated with Wilson\u2019s disease","volume":"43","author":"Iwadate","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00005176-200311000-00023","article-title":"Metastatic hepatocellular carcinoma in a patient with niemann-pick disease, type C","volume":"37","author":"Birch","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.bpg.2010.07.008_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-2005-871201","article-title":"Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature","volume":"25","author":"Xu","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.008_bib20","first-page":"1389","article-title":"Occurrence of hepatocellular carcinoma in a case of hereditary coproporphyria","volume":"92","author":"Andant","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.008_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/hep.21196","article-title":"Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma","volume":"43","author":"Branda","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.11.010","article-title":"Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis","volume":"252","author":"Feitelson","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bpg.2010.07.008_bib23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpg.2010.07.008_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2006-960171","article-title":"Genomics and signaling pathways in hepatocellular carcinoma","volume":"27","author":"Villanueva","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.008_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0030-1247131","article-title":"Molecular classification and novel targets in hepatocellular carcinoma: recent advancements","volume":"30","author":"Hoshida","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.008_bib26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/CCO.0b013e328302c9e9","article-title":"Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps","volume":"20","author":"Villanueva","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bpg.2010.07.008_bib27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Hoshida","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib28","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1038\/sj.onc.1202800","article-title":"Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity","volume":"18","author":"Legoix","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bpg.2010.07.008_bib29","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","article-title":"Pivotal role of mTOR signaling in hepatocellular carcinoma","volume":"135","author":"Villanueva","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.008_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jhep.2009.03.028","article-title":"Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo","volume":"51","author":"Newell","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2010.01.015","article-title":"IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage","volume":"52","author":"Tovar","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI27236","article-title":"Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype","volume":"116","author":"Kaposi-Novak","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2010.07.008_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jhep.2004.09.006","article-title":"Angiogenesis and hepatocellular carcinoma","volume":"41","author":"Semela","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.med.080608.100623","article-title":"Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy","volume":"61","author":"Villanueva","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib35","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1158\/0008-5472.CAN-08-0742","article-title":"Focal gains of VEGFA and molecular classification of hepatocellular carcinoma","volume":"68","author":"Chiang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.008_bib36","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0030-1247128","article-title":"Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis","volume":"30","author":"Sherman","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.008_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1148\/radiol.2342031202","article-title":"Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis","volume":"234","author":"Iannaccone","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2010.07.008_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.21966","article-title":"Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma","volume":"47","author":"Forner","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1247133","article-title":"Current strategy for staging and treatment: the BCLC update and future prospects","volume":"30","author":"Forner","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.008_bib41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2010.07.008_bib42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort","volume":"41","author":"Marrero","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jhep.2009.01.005","article-title":"Clinical trial design and evidence-based outcomes in the study of liver diseases","volume":"50","author":"Croswell","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib44","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.02932.x","article-title":"Systematic review: evidence-based management of hepatocellular carcinoma\u2013an updated analysis of randomized controlled trials","volume":"23","author":"Lopez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.07.008_bib45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2008.05.018","article-title":"Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey","volume":"49","author":"Hasegawa","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib48","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/lt.21018","article-title":"Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal","volume":"12","author":"Lopez","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2010.07.008_bib49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2010.07.008_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hep.21933","article-title":"Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?","volume":"47","author":"Livraghi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib51","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1572-0241.2008.01955.x","article-title":"Liver disease in alpha 1-antitrypsin deficiency: a review","volume":"103","author":"Fairbanks","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.008_bib52","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mcna.2004.08.005","article-title":"Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention","volume":"89","author":"Harrison","year":"2005","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.bpg.2010.07.008_bib53","first-page":"160","article-title":"Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review","volume":"65","author":"Kok","year":"2007","journal-title":"Neth J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpg.2010.07.008_bib56","first-page":"386A","article-title":"Molecular gene signature to identify vascular invasion in hepatocellular carcinoma","volume":"48","author":"Minguez","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2005-871198","article-title":"Resection and liver transplantation for hepatocellular carcinoma","volume":"25","author":"Llovet","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.008_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000094532","article-title":"Surgery for hepatocellular carcinoma arising in hereditary hemochromatosis","volume":"38","author":"Sotiropoulos","year":"2006","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.bpg.2010.07.008_bib59","first-page":"307","article-title":"Surgical management of hepatocellular carcinoma in genetic haemochromatosis","volume":"94","author":"Landen","year":"1994","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.bpg.2010.07.008_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/003693309804300408","article-title":"Early diagnosis of hepatocellular carcinoma in haemochromatosis influences surgical management","volume":"43","author":"Pleass","year":"1998","journal-title":"Scott Med J"},{"key":"10.1016\/j.bpg.2010.07.008_bib61","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hep.1840200221","article-title":"Outcome of liver transplantation in patients with hemochromatosis","volume":"20","author":"Farrell","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/lt.500010408","article-title":"Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis","volume":"1","author":"Kowdley","year":"1995","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.bpg.2010.07.008_bib63","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.07.008_bib64","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.008_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.bpg.2010.07.008_bib67","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.008_bib68","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.008_bib69","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bpg.2010.07.008_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpg.2010.07.008_bib71","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.008_bib72","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1200\/JCO.2006.06.5599","article-title":"Measures of response: RECIST, WHO, and new alternatives","volume":"24","author":"Jaffe","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.07.008_bib73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T17:06:09Z","timestamp":1560013569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691810000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1521691810000879"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2010.07.008","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}